Company Overview

Update
Founded:
1999
Headquarters:
Cap Delta Biopole Euromédecine II
Funding:
$1.30M
Categories:
Biotechnology

Skuldtech innovates diagnostics associated with new treatments for cancer and neurodegenerative and infectious diseases.

Description

Update

Skuldtech is specialized in the discovery of new Biomarkers and the development of Diagnostics focused on personalized medicine applications. This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as innovative diagnostics associated with new treatments, especially in cancer, neurodegenerative and infectious diseases.

Funding Rounds (1) - $1.30M

Update

Investors (1)

Update
  • E4c24185de183573a76a9ea1d885a74a

    Bpifrance

    Bpifrance provides financial solutions for companies that are booting up the listing on the stock..

Offices/Locations (1)

Update
  • Office

    1682, rue de la Valsière

    CS 77394

    Cap Delta Biopole Euromédecine II, 34184

    FRA

Images (1)

Update
  • 206ed1b5251fc5d2c358ab6eac8c7165